logo Kompas.id
β€Ί
Englishβ€ΊImprove Coordination between...
Iklan

Improve Coordination between BPOM and Researchers

Coordination between the Food and Drug Monitoring Agency (BPOM) and the Nusantara vaccine research team should also be improved.

By
DEONISIA ARLINTA
Β· 1 menit baca
https://cdn-assetd.kompas.id/53AYYO3RxjbSbQdP2VP5x2O0B3M=/1024x576/filters:watermark(https://cdn-content.kompas.id/umum/kompas_main_logo.png,-16p,-13p,0)/https%3A%2F%2Fkompas.id%2Fwp-content%2Fuploads%2F2021%2F02%2F256f54c2-34e5-4b47-b586-ea33527a0ec2_jpg.jpg
KOMPAS/ADITYA PUTRA PERDANA

Activity of officers at the Clinical Pathology Laboratory of Dr. Kariadi Hospital, Semarang, Central Java, Wednesday (17/2/2021).

JAKARTA, KOMPAS β€” While there have been ups and downs in the development of the Nusantara vaccine, its scientific basis should continue to be prioritized. The research conducted should ensure that the Covid-19 vaccine is safe, of good quality and effective. Coordination between the Food and Drug Monitoring Agency (BPOM) and the Nusantara vaccine research team should also be improved.

Chairman of the Expert Team concurrently National Covid-19 Task Force Spokesman Wiku Adisasmito said in Jakarta on Thursday (15/4/2021) that the Nusantara vaccine or dendritic vaccine was the vaccine type worked out in the United States and subject to clinical trials in Indonesia. The government supports the development of all Covid-19 vaccines, including the Nusantara vaccine, as long they fulfill relevant requirements.

Editor:
Syahnan Rangkuti
Bagikan